Your browser doesn't support javascript.
loading
A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.
Chowdhury, Fahima; Akter, Afroza; Bhuiyan, Taufiqur Rahman; Tauheed, Imam; Teshome, Samuel; Sil, Arijit; Park, Ju Yeon; Chon, Yun; Ferdous, Jannatul; Basher, Salima Raiyan; Ahmed, Faez; Karim, Mahbubul; Ahasan, Mohammad Mainul; Mia, Masudur Rahman; Masud, Mir Mohammad Ibna; Khan, Abdul Wahab; Billah, Masum; Nahar, Zebun; Khan, Imran; Ross, Allen G; Kim, Deok Ryun; Ashik, Md Muktadir Rahman; Digilio, Laura; Lynch, Julia; Excler, Jean-Louis; Clemens, John D; Qadri, Firdausi.
Afiliação
  • Chowdhury F; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh; Menzies Health Institute Queensland, Gold Coast, Australia.
  • Akter A; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh.
  • Bhuiyan TR; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh.
  • Tauheed I; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh.
  • Teshome S; International Vaccine Institute (IVI), Seoul, Republic of Korea.
  • Sil A; International Vaccine Institute (IVI), Seoul, Republic of Korea.
  • Park JY; International Vaccine Institute (IVI), Seoul, Republic of Korea.
  • Chon Y; International Vaccine Institute (IVI), Seoul, Republic of Korea.
  • Ferdous J; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh.
  • Basher SR; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh.
  • Ahmed F; Incepta Vaccine Limited, Dhaka, Bangladesh.
  • Karim M; Incepta Vaccine Limited, Dhaka, Bangladesh.
  • Ahasan MM; Incepta Vaccine Limited, Dhaka, Bangladesh.
  • Mia MR; Incepta Vaccine Limited, Dhaka, Bangladesh.
  • Masud MMI; Incepta Vaccine Limited, Dhaka, Bangladesh.
  • Khan AW; Incepta Vaccine Limited, Dhaka, Bangladesh.
  • Billah M; Incepta Vaccine Limited, Dhaka, Bangladesh.
  • Nahar Z; Incepta Vaccine Limited, Dhaka, Bangladesh.
  • Khan I; Incepta Vaccine Limited, Dhaka, Bangladesh.
  • Ross AG; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh; Menzies Health Institute Queensland, Gold Coast, Australia.
  • Kim DR; International Vaccine Institute (IVI), Seoul, Republic of Korea.
  • Ashik MMR; Incepta Vaccine Limited, Dhaka, Bangladesh.
  • Digilio L; International Vaccine Institute (IVI), Seoul, Republic of Korea.
  • Lynch J; International Vaccine Institute (IVI), Seoul, Republic of Korea.
  • Excler JL; International Vaccine Institute (IVI), Seoul, Republic of Korea.
  • Clemens JD; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh; UCLA Fielding School of Public Health, Los Angeles, CA, USA; Korea University School of Medicine, Seoul, South Korea.
  • Qadri F; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh. Electronic address: fqadri@icddrb.org.
Vaccine ; 40(4): 640-649, 2022 01 28.
Article em En | MEDLINE | ID: mdl-34969541

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Cólera / Cólera / Vibrio cholerae O1 Tipo de estudo: Clinical_trials Limite: Humans / Infant País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Cólera / Cólera / Vibrio cholerae O1 Tipo de estudo: Clinical_trials Limite: Humans / Infant País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália País de publicação: Holanda